Rate this article:

Favourite Article of 2014 Poll Results


Of the top 5 BJUI papers of 2014, which is your favourite?

Favourite Article Poll Results


Guideline of guidelines: prostate cancer screening – 38.24%

The transcriptional programme of the androgen receptor (AR) in prostate cancer – 11.76%

Phase III, randomised, double‐blind, placebo‐controlled study of the β3‐adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder – 5.88%

Engaging responsibly with social media: the BJUI guidelines – 38.24%

Penile vibratory stimulation in the recovery of urinary continence and erectile function after nerve‐sparing radical prostatectomy: a randomized, controlled trial – 5.88%


Please note that all submitted comments will be reviewed by the BJUI Web Team before they are considered for publishing on the site. Comments may take up to 48 hours to go live. If you have made a comment which has not appeared live after this time and you wish to discuss this matter further, please contact us.